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SUMMARY
Meta-analysis is widely used to synthesize the results of multiple studies. Although meta-
analysis is traditionally carried out by combining the summary statistics of relevant studies,
advances in technologies and communications have made it increasingly feasible to access the
original data on individual participants. In the present paper, we investigate the relative efficiency
of analyzing original data versus combining summary statistics. We show that, for all commonly
used parametric and semiparametric models, there is no asymptotic efficiency gain by analyzing
original data if the parameter of main interest has a common value across studies, the nuisance
parameters have distinct values among studies, and the summary statistics are based on maximum
likelihood. We also assess the relative efficiency of the two methods when the parameter of main
interest has different values among studies or when there are common nuisance parameters across
studies. We conduct simulation studies to confirm the theoretical results and provide empirical
comparisons from a genetic association study.
Some key words: Cox regression; Evidence-based medicine; Genetic association; Individual patient data; Information
matrix; Linear regression; Logistic regression; Maximum likelihood; Profile likelihood; Research synthesis.
1. INTRODUCTION
Meta-analysis, the combination of results from a series of independent studies, is gaining
popularity in many fields, including medicine, psychology, epidemiology, education, genetics and
ecology. In particular, meta-analysis publications in medical research have grown enormously
over the last three decades, due to greater emphasis on evidence-based medicine and the need for
reliable summarization of the vast and expanding volume of clinical research (e.g. Sutton et al.,
2000; Whitehead, 2002). Most of the recent discoveries on genetic variants influencing complex
human diseases were made possible through meta-analysis of multiple studies (e.g. Lohmueller
et al., 2003; Zeggini et al., 2008).
Traditionally, meta-analysis is carried out by combining the summary statistics of relevant
studies, which are available in journal articles. With improving technologies and communications
and increasing recognition of the benefits of meta-analysis, it is becoming more feasible to access
the raw or original data on individual participants (e.g. Sutton et al., 2000). Indeed, meta-analysis
of individual patient data is regarded as the gold standard in systematic reviews of randomized
clinical trials (e.g. Chalmers et al., 1993). Recently, a number of networks and consortia have
been created to share original data from genetic association studies (e.g. Kavvoural & Ioannidis,
2008; The Psychiatric GWAS Consortium Steering Committee, 2009). In general, obtaining
original data is difficult, costly and time-consuming. A question naturally arises as to how much
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efficiency gain can be achieved by analyzing original or individual-level data over combining
summary statistics.
A partial answer to this question was provided by Olkin & Sampson (1998), who showed
that, in the case of comparing multiple treatments and a control with respect to a continuous
outcome, the traditional meta-analysis based on estimated treatment contrasts is equivalent to
the least-squares regression analysis of individual patient data if there are no study-by-treatment
interactions and the error variances are constant across trials. Mathew & Nordström (1999)
claimed that the equivalence holds even if the error variances are different across trials. There
has been no theoretical investigation beyond this special setting. Empirically, meta-analysis using
original data has been found to be generally similar but not identical to meta-analysis using
summary statistics (e.g. Whitehead, 2002, Ch. 5).
In the present paper, we provide a systematic investigation into the relative efficiency of using
summary statistics versus original data in fixed-effects meta-analysis, which assumes a common
effect among studies. We prove that the two types of meta-analysis are asymptotically equivalent
for all commonly used parametric and semiparametric models provided that the effect sizes are
indeed the same for all studies, the nuisance parameters have different values across studies, and
maximum likelihood estimation is used in the calculations of summary statistics and in the joint
analysis of original data. We also investigate the relative efficiency of the two methods when the
effect sizes are different among studies or when there are common nuisance parameters across
studies. We illustrate the theoretical results with simulated and empirical data.
2. THEORETICAL RESULTS
2·1. Main results
Suppose that there are K independent studies, with nk participants for the kth study. The original
data consist of (Yki , Xki ) (k = 1, . . . , K ; i = 1, . . . , nk), where Yki is the response variable for the
i th participant of the kth study, and Xki is the corresponding vector of explanatory variables. The
response variable can be continuous or discrete, univariate or multivariate. Under fixed-effects
models, the conditional density of Yki given Xki takes the form f (y, x ; β, ηk), where β is a vector
of parameters common to all K studies, and ηk is a vector of parameters specific to the kth study.
A simple example is the linear regression model for the normal response variable:
Yki = αk + βT Xki + εki (k = 1, . . . , K ; i = 1, . . . , nk),
where εki is normal with mean zero and variance σ 2k (Whitehead, 2002, § 5.2.1). In this case,
f (y, x ; β, ηk) = (2πσ 2k )−1/2 exp{−(y − αk − βTx)2/2σ 2k }, and ηk = (αk, σ 2k ). Additional exam-
ples are given in § 2·4. We wish to make inference about β.
Meta-analysis is usually performed on a scalar parameter. We allow vector-valued β for two
reasons. First, there are important applications in which the effects of interest, such as treatment
differences in a multi-arm clinical trial or co-dominant effects of a genetic variant, are truly
multivariate. Second, if the nuisance parameters, e.g. intercepts or confounding effects, have the
same values among the K studies, then performing meta-analysis jointly on the effects of interest
and the common nuisance parameters can improve statistical efficiency, as will be discussed in
§ 2·2. Of course, our formulation includes scalar β as a special case.




f (Yki , Xki ; β, ηk),
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and let β̃ be the maximum likelihood estimator of β by maximizing the joint likelihood











L(β, η1, . . . , ηK ).
The corresponding observed profile information matrices are Ik(β) = −∂2 log plk(β)/∂β2 and
I(β) = −∂2 log pl(β)/∂β2. The maximizer of the profile likelihood is the same as the maximum
likelihood estimator in that β̂k = argmax plk(β) and β̃ = argmax pl(β). Write n = ∑k nk and
assume that nk/n → ck ∈ (0, 1) as n → ∞. Assume also that the regularity conditions for profile
likelihood as stated in Murphy & van der Vaart (2000) hold. Then nkI−1k (β̂k) and nI−1(β̃)
are consistent estimators of the covariance matrices of n1/2k (β̂k − β) and n1/2(β̃ − β), respectively.
Remark 1. For survival data and other censored data, the likelihood needs to be modified. If Yki
is right censored at Ỹki , then we replace f (Yki , Xki ; β, ηk) in the likelihood by S(Ỹki , Xki ; β, ηk),
where S(y, x ; β, ηk) =
∫ ∞
y f (u, x ; β, ηk)du.
Remark 2. Our framework allows different likelihood functions among studies, and the sta-
tistical models are not necessarily regression models. In meta-analysis of diagnostic accuracy
data, the likelihood for each study pertains to the multinomial distribution of a 2 × 2 contingency
table, and β can be sensitivity or specificity or both.
In traditional meta-analysis, one collates summary statistics β̂k and ˆvar(β̂k) = 1/Ik(β̂k) (k =



























Clearly, (3) and (4) reduce to (1) and (2) if β is a scalar. If original data are available, one
can estimate β by the maximum likelihood estimator β̃, whose covariance matrix is estimated
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Equations (4) and (5) show that ˆvar(β̂) and ˆvar(β̃) take the same form; the only difference
is that Ik(β) are evaluated at β̂k in the former and at β̃ in the latter. Under standard regularity
conditions, β̂k (k = 1, . . . , K ) and β̃ converge to β, and n−1k Ik(β) (k = 1, . . . , K ) converge to
constant matrices. It follows that n1/2(β̂ − β) and n1/2(β̃ − β) have the same limiting normal
distribution. Thus, using summary statistics has the same asymptotic efficiency as using original
data.
2·2. Common nuisance parameters
According to the results of the last section, meta-analysis based on summary statistics has the
same asymptotic efficiency as the maximum likelihood estimator of full data if the former analysis
is performed jointly on all common parameters. It is generally difficult to obtain multivariate
summary statistics, especially in retrospective meta-analysis of published results. Thus, it is
important to determine the efficiency loss of meta-analysis based on the univariate summary
statistics for the effect of main interest when there are other common effects, which are referred
to as common nuisance parameters.
Suppose that β is a scalar parameter representing a common effect of main interest and that
a subset of ηk , denoted by γ , is a vector of common nuisance parameters. Denote the profile










respectively. The variance of β̂k is approximately (Ikββ − IkβγI−1kγ γIkγβ)−1, so the variance of
β̂ is approximately {∑k(Ikββ − Ikβγ I−1kγ γIkγβ)}−1. The variance of β̃ is approximately (Iββ −




Iββ − IβγI−1γ γ Iγβ
.



























Thus, the relative efficiency is always less than or equal to 1. It also follows from Lemma 1 that
the relative efficiency is 1 if and only if IkβγI−1kγ γ = Ilβγ I−1lγ γ (∀k  l). Note that Ikβγ I−1kγ γ ≈
−var(β̂k)−1cov(β̂k, γ̂k), where β̂k and γ̂k are the maximum likelihood estimators of β and γ
based on the kth study data. Thus, the relative efficiency is 1 if and only if var(β̂k)−1cov(β̂k, γ̂k)
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are the same among the K studies. Obviously, the latter condition is satisfied if cov(β̂k, γ̂k) = 0
(k = 1, . . . , K ). The foregoing conclusions also hold for multivariate β.
2·3. Unequal effect sizes
The fixed-effects meta-analysis assumes that the effect sizes βk are the same across studies.
This assumption does not affect the Type I error of hypothesis testing since all effect sizes are the
same under the null hypothesis. However, it is of practical importance to determine the relative
power of using summary statistics versus original data when the βk are unequal.
Write Uk(β) = ∂ log plk(β)/β and U (β) = ∂ log pl(β)/β. By definition, Uk(β̂k) = 0 (k =
1, . . . , K ) and U (β̃) = 0. Since U (β) = ∑Kk=1 Uk(β), we have ∑Kk=1{Uk(β̂k) − Uk(β̃)} = 0. By
the mean-value theorem,
∑K









Ik(β∗k )β̂k . (6)
Comparison of (6) to (3) reveals that β̃ is the same kind of weighted combination of β̂k as β̂, with
the weights Ik(β) evaluated at β∗k rather than β̂k . As shown in § 2·1, the only difference between
ˆvar(β̃) and ˆvar(β̂) lies in the evaluation of Ik(β) at β̃ versus β̂k . Hence, meta-analysis based on
summary statistics and meta-analysis of original data will have similar power provided that the
Ik(β) do not change their values drastically when β varies between β̂k and β̃. When the βk are
unequal, the limits of β̂ and β̃ pertain to weighted combinations of βk , rather than a common
parameter in a statistical model.
We consider the local alternatives H1n : β
(n)
k = β + O(n−1/2) (k = 1, . . . , K ). Under H1n , the
estimators β̂k (k = 1, . . . , K ) converge in probability to β. We show in Appendix B that β̃ also
converges in probability to β under H1n . It follows that, for each k, the weights n−1Ik(β̂k),
n−1Ik(β̃) and n−1Ik(β∗k ) all converge in probability to the same constant matrix. Thus, meta-
analysis based on summary statistics and meta-analysis of original data have the same asymptotic
power against H1n .
For hypothesis testing, one can use score statistics in meta-analysis. For testing the null













and U T(β0)I−1(β0)U (β0), respectively. The two statistics are numerically identical since U (β) =∑K
k=1 Uk(β) and I(β) =
∑K
k=1 Ik(β). This equivalence holds whether the true effect sizes are
equal or not.
2·4. Special cases
In this section, we consider the three most common cases of meta-analysis: linear regression for
continuous response, logistic regression for binary response and Cox regression for potentially
censored survival time. We will pay particular attention to the form of the observed profile
information matrices Ik because, as shown in §§ 2·1 and 2·3, the only difference between β̂ and
β̃ lies in the argument of the profile information matrix. We use X to denote the explanatory
variables of main interest and Z to denote the unit component and possibly other explanatory
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variables or covariates. The numbers and types of covariates need not be the same among the K
studies.
Example 1. Assume that the distribution of Yki conditional on Xki and Zki is normal with
mean βT Xki + γ Tk Zki and variance σ 2k . The observed profile information matrix for β based on


















and a⊗2 = aaT. The maximum likelihood estimators of σ 2k based on the kth study data and all
data are, respectively,




Yki − β̂Tk Xki − γ̂ Tk Zki




Yki − β̃T Xki − γ̃ Tk Zki
)2
,
where β̂k and γ̂k are the least-squares estimators of β and γk based on the kth study data,
and β̃ and γ̃k are the maximum likelihood estimators of β and γk based on all data. By def-
inition, β̂ = {∑k Ik(σ̂ 2k )}−1 ∑k Ik(σ̂ 2k )β̂k and ˆvar(β̂) = {∑k Ik(σ̂ 2k )}−1. It is easy to show that
β̃ = {∑k Ik(σ̃ 2k )}−1 ∑k Ik(σ̃ 2k )β̂k and ˆvar(β̃) = {∑k Ik(σ̃ 2k )}−1. Thus, β̂ and β̃, and their vari-
ance estimators, differ only in whether Ik(σ 2k ) is evaluated at σ̂ 2k or σ̃ 2k . In general, σ̂ 2k and σ̃ 2k are
approximately the same, so that the results of meta-analysis using summary statistics and using
original data are similar. Under the assumed model, both σ̂ 2k and σ̃
2
k converge to σ
2
k , so that using
summary statistics is asymptotically equivalent to using original data. If the assumed model is
incorrect, then the two estimators may converge to different constants.
The setting considered by Olkin & Sampson (1998) and Mathew & Nordström (1999) is a
special case of our model in which X consists of treatment indicators and Z = 1. In that setting,





k Dk β̂k , which also turns out to be the expression of β̃ under the common
variance assumption. Thus, using summary statistics is numerically identical to using original
data, which is the finding of Olkin & Sampson (1998). Mathew & Nordström (1999) stated that
the equivalence continues to hold even if the error variances are unequal. They used the true
values of σ 2k in their definition of β̂. Since σ
2
k need to be estimated from the data, the equivalence
holds only asymptotically rather than numerically.
Example 2. Assume that
pr(Yki = 1 | Xki , Zki ) = exp
(
βT Xki + γ Tk Zki
)
1 + exp (βT Xki + γ Tk Zki) (k = 1, . . . , K ; i = 1, . . . , ni ).
























where vki (θk) = eβT Xki +γ Tk Zki /(1 + eβT Xki +γ Tk Zki )2. Note that Ik depends on θk only through the
vki (θk). Clearly, vki (θk) = pr(Yki = 1){1 − pr(Yki = 0)}, which is not sensitive to the value of θk
unless pr(Yki = 1) is extreme. Thus, the results of meta-analysis using summary statistics and
using original data are generally similar, whether the effect sizes are equal or not.
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Example 3. The Cox (1972) proportional hazards model specifies that the hazard function of
the survival time Yki conditional on covariates Xki takes the form
λ(y | Xki ) = λk0(y) exp(βT Xki ) (k = 1, . . . , K ; i = 1, . . . , ni ),
where λk0(·) are arbitrary baseline hazard functions. In the presence of right censoring, the
data consist of (Ỹki ,ki , Xki ) (k = 1, . . . , K ; i = 1, . . . , nk), where Ỹki = min(Yki , Cki ), ki =
I (Yki  Cki ), Cki is the censoring time on Yki and I (·) is the indicator function. The observed




j=1 I (Ỹk j  y) exp(βT Xkj )X⊗2k j∑nk
j=1 I (Ỹk j  y) exp(βT Xkj )
−
{∑nk
j=1 I (Ỹk j  y) exp(βT Xkj )Xkj∑nk
j=1 I (Ỹk j  y) exp(βT Xkj )
}⊗2
.
Here Vk(β; y) is an empirical covariance matrix of X and is not sensitive to the value of β. Thus,
the results of meta-analysis using summary statistics and using original data are similar whether
the effect sizes are equal or not.
3. NUMERICAL RESULTS
3·1. Simulation studies
We conducted simulation studies to assess how well the asymptotic efficiency results of § 2
approximate realistic situations. We mimicked meta-analysis of randomized clinical trials with a
binary outcome and simulated data from the following logistic regression model:
pr(Yki = 1 | Xki ) = exp(αk + β − k Xki )
1 + exp(αk + β − k Xki ) (k = 1, . . . , K ; i = 1, . . . , nk), (7)
where Xki is the treatment indicator, and the proportion of subjects receiving treatment 1 in the
kth trial is pk . The first set of simulation studies was focused on K = 2. We set α1 = 0 and
α2 = −1 to yield approximately 50% and 30% overall success rates, and chose various values of
β1, β2, n1, n2, p1 and p2 to cover a wide range of log odds ratios, sample sizes and treatment
assignment ratios. For each combination of the simulation parameters, we generated 1 million
datasets; for each dataset, we performed the two types of meta-analysis, i.e. the one based on
summary statistics versus the one based on original data. The results are summarized in Table 1.
When the effect sizes are the same between the two studies, i.e. β1 = β2, both β̂ and β̃ are
nearly unbiased, and their standard errors are close to each other. Thus, the two types of meta-
analysis have similar efficiency. To be more specific, β̂ appears to have slightly smaller standard
error than β̃ and is thus a little more efficient in that sense; however, β̃ is slightly biased upward
and its standard error tends to be slightly underestimated, so that the corresponding Wald test
tends to be slightly more powerful than that of β̂. When the effect sizes are unequal between
the two studies, i.e. β1  β2, the differences between the two methods become more appreciable.
In many cases, meta-analysis based on original data is a little more powerful than meta-analysis
based on summary statistics. There are also cases in which the latter is slightly more powerful
than the former.
In the second set of studies, we simulated K trials of size n from (7) with αk = −1, βk = 1
and pk = 0·5 (k = 1, . . . , K ). For both meta-analysis of summary statistics and meta-analysis
of original data, the K intercepts might be assumed to be the same or allowed to be different.
To impose a common intercept in meta-analysis of summary statistics, we used the bivariate
summary statistics for (αk, βk). Table 2 displays the relative efficiency results based on 10 000
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Table 1. Meta-analysis based on summary statistics versus original data
Summary statistics Original data
β1 β2 p1 p2 n1 n2 Mean SE SEE Power Mean SE SEE Power
0·8 0·8 0·5 0·5 100 100 0·807 0·302 0·302 0·772 0·813 0·304 0·301 0·775
100 200 0·805 0·247 0·247 0·912 0·809 0·248 0·246 0·913
200 100 0·805 0·244 0·245 0·917 0·809 0·246 0·244 0·918
0·2 0·5 100 100 0·803 0·337 0·340 0·665 0·817 0·342 0·338 0·685
100 200 0·801 0·264 0·266 0·866 0·810 0·266 0·265 0·874
200 100 0·805 0·286 0·287 0·818 0·814 0·289 0·285 0·826
0·5 0·2 100 100 0·810 0·327 0·330 0·698 0·812 0·331 0·328 0·702
100 200 0·805 0·277 0·278 0·830 0·807 0·279 0·276 0·832
200 100 0·808 0·257 0·258 0·885 0·808 0·259 0·257 0·884
0·5 1·0 0·5 0·5 100 100 0·744 0·294 0·298 0·717 0·753 0·298 0·296 0·730
100 200 0·829 0·242 0·244 0·935 0·834 0·244 0·243 0·937
200 100 0·658 0·238 0·240 0·793 0·666 0·240 0·239 0·807
0·2 0·5 100 100 0·804 0·332 0·334 0·681 0·817 0·339 0·333 0·695
100 200 0·879 0·261 0·263 0·928 0·887 0·265 0·263 0·929
200 100 0·715 0·280 0·280 0·732 0·726 0·284 0·280 0·745
0·5 0·2 100 100 0·698 0·323 0·324 0·581 0·703 0·329 0·324 0·587
100 200 0·783 0·275 0·274 0·820 0·787 0·278 0·274 0·818
200 100 0·621 0·253 0·253 0·693 0·625 0·256 0·253 0·696
1·0 0·5 0·5 0·5 100 100 0·760 0·305 0·308 0·701 0·770 0·310 0·306 0·712
100 200 0·672 0·249 0·251 0·771 0·681 0·252 0·250 0·781
200 100 0·843 0·248 0·250 0·931 0·849 0·250 0·249 0·932
0·2 0·5 100 100 0·685 0·335 0·348 0·500 0·712 0·342 0·341 0·553
100 200 0·611 0·264 0·271 0·621 0·631 0·267 0·267 0·661
200 100 0·779 0·284 0·294 0·777 0·796 0·290 0·289 0·800
0·5 0·2 100 100 0·817 0·322 0·338 0·690 0·813 0·330 0·330 0·696
100 200 0·720 0·272 0·284 0·727 0·722 0·277 0·278 0·739
200 100 0·890 0·256 0·265 0·932 0·884 0·260 0·261 0·929
Mean, mean parameter estimates; SE, standard errors; SEE, mean standard error estimates; Power, power at the 0·05
significance level.
Table 2. Relative efficiency of using summary statistics versus original data in meta-analysis
K = 20 K = 50 K = 100
n RE1 RE2 RE3 RE1 RE2 RE3 RE1 RE2 RE3
10 1·108 0·968 1·093 1·113 0·966 1·097 1·112 0·967 1·098
20 1·161 1·010 1·112 1·160 1·006 1·113 1·156 1·004 1·110
50 1·092 1·017 1·065 1·096 1·021 1·068 1·096 1·022 1·069
100 1·049 1·007 1·030 1·047 1·007 1·029 1·046 1·007 1·030
RE1 is the relative efficiency of meta-analysis of summary statistics with a common intercept to meta-analysis of
original data with a common intercept; RE2 is the relative efficiency of meta-analysis of summary statistics with
different intercepts to meta-analysis of original data with a common intercept; RE3 is the relative efficiency of
meta-analysis of summary statistics with different intercepts to meta-analysis of original data with different intercepts.
replicates with nonzero cell counts. Meta-analysis of summary statistics appears to be as efficient
as, or slightly more efficient than, meta-analysis of original data when the two methods make the
same modelling assumptions. For n = 10, meta-analysis of original data with a common intercept
is a bit more efficient than meta-analysis of summary statistics with different intercepts.
Meta-analysis 329
3·2. Major depression data
Major depression is a complex common disease with enormous public health significance.
The lifetime prevalence of this disorder is approximately 15% and is two-fold higher in women
than men. Recently, a genome-wide association study was conducted to identify single nucleotide
polymorphisms, SNPs, that are associated with major depression (Sullivan et al., 2009). Using
a case-control sample of 1738 cases and 1802 controls, the investigators found strong signals
in a region surrounding the gene piccolo, PCLO. The investigators then attempted to replicate
the results with five independent case-control samples. For our illustration, we exclude the two
replication samples that do not have information on sex, which is an important predictor of major
depression. The remaining three replication samples have 1907, 2489 and 2005 subjects, with a
total of 3135 cases and 3266 controls.
A total of 30 SNPs in the PCLO region were genotyped in the replication samples. For each
SNP, we fit the logistic regression model
pr(Yki = 1 | Xki , Zki ) = exp(αk + β Xki + γk Zki )
1 + exp(αk + β Xki + γk Zki ) (k = 1, . . . , 3; i = 1, . . . , nk),
(8)
where Yki is the case-control status of the i th subject in the kth sample, and Xki and Zki are
the corresponding genotype score and sex indicator; the genotype score is the number of copies
of the less frequent nucleotide of the SNP that the subject carries. The estimates of the genetic
effects and their standard error estimates vary substantially among the three replication samples.
For meta-analysis of summary statistics, the estimates of the genetic effects pre-adjusted for sex
from the three samples are combined according to formula (1).
We allow αk in (8) to be different among the three samples so as to reflect the unequal case-
control ratios; γk may be the same or different among the three samples. When γk are allowed to
be different in both the meta-analysis based on summary statistics and the meta-analysis based
on original data, the two methods yield virtually identical results for the genetic effects of the 30
SNPs: the largest absolute difference between the two sets of log odds ratio estimates is 0·00066,
and the largest relative difference between the two sets of standard error estimates is 0·25%.
When γk are assumed to be the same among the three replication samples in the meta-analysis of
original data but not in the meta-analysis of summary statistics, the differences between the two
methods become slightly more noticeable: the largest absolute difference between the two sets
of log odds ratio estimates is 0·0045, and the largest relative difference between the two sets of
standard error estimates is 0·35%. Incidentally, the covariance estimates between β̂k and γ̂k are
virtually zero, so the differences should be small in light of the results of § 2·2.
4. REMARKS
The theoretical results of the present paper are much broader than those of Olkin & Sampson
(1998) and Mathew & Nordström (1999), even in the special setting considered by those authors;
we have clarified the conditions for the equivalence results stated in those two papers and examined
the consequences of violating the underlying assumptions. We have considered more general
models for continuous response variables, as well as general parametric and semiparametric
models for other response variables.
Our work has important practical implications. There is an ongoing debate on whether the
benefits of using original data outweigh the extra cost of taking this approach. The statistical
issues surrounding this debate have not been understood well. We have shown theoretically and
numerically that there is little or no efficiency gain by analyzing original data. Meta-analysis
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based on summary statistics reduces resource utilization, simplifies data collection and analysis
and avoids the bias and efficiency loss caused by exclusion of studies without original data.
By accessing original data, one can enhance comparability among studies with respect to
inclusion/exclusion criteria, definitions of variables, creations of subgroups and adjustments of
covariates, ensure estimation of the same parameter by the same statistical method and perform
model building and diagnostics. Many of these benefits can still be achieved if all participating
investigators follow a common set of guidelines on quality control and statistical analysis and then
submit their summary statistics to the meta-analyst. Providing summary statistics is logistically
much simpler than transferring original data. Indeed, protection of human subjects and other
study policies often prohibit investigators from releasing original data.
One reason for obtaining original data is to model individual-level covariates. It is widely
recognized that using study-level summaries of covariates can yield highly biased and inefficient
meta-analysis (Berlin et al., 2002; Lambert et al., 2002). We have shown theoretically and
numerically that there is no bias or efficiency loss if the effect estimates are properly adjusted for
individual-level covariates within each study and then combined via formula (1) or (3). The results
of § 2 apply not only to meta-analysis of main effects, but also to meta-analysis of interactions,
such as treatment-covariate interactions. If study-specific estimates of interactions are unavailable
and one is forced to estimate interactions from study-specific main effects and average covariate
values, then there can be serious power loss and bias (Simmonds & Higgins, 2007).
In our context, the asymptotics pertain to individual study sizes nk . For commonly used
parametric and semiparametric models, such as linear, logistic and Cox regression models, the
asymptotic approximations are accurate even for small nk . When the data for individual studies
are very sparse, the parameter estimates may be undefined or unreliable. Then analysis of original
data will encounter the same difficulties if it is stratified by studies but will tend to be more
stable if it is unstratified. Unstratified analysis is more efficient than stratified analysis, but can
be misleading if the underlying populations are different among studies. If individual studies are
very small, then model building and diagnostics are possible only by pooling the data.
We have focused on fixed-effects models, which assume a common value for the parameter
of main interest among studies. An alternative approach is to employ random-effects models, in
which the parameter of main interest is treated as a random variable with different realizations
across studies (DerSimonian & Laird, 1986). It is technically more challenging to deal with
random-effects models than fixed-effects models. Indeed, the properties of meta-analysis under
random-effects models have not been investigated rigorously. Our preliminary investigations
reveal that the conclusions of § 2 hold for random-effects models under certain conditions. The
results will be communicated in a separate report.
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APPENDIX A
Some useful matrix results
LEMMA 1. For any matrices Ap×q , Bq×q , C p×q and Dq×q with B > 0 and D > 0,
AB−1 AT + C D−1CT  (A + C)(B + D)−1(A + C)T. (A1)
The equality holds if and only if AB−1 = C D−1.
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Proof . Since B > 0 and D > 0, we can find a nonsingular matrix P such that B = Pdiag{λ1, . . . , λq}PT
and D = Pdiag{μ1, . . . , μq}PT, where λi > 0 and μi > 0 (i = 1, . . . , q). By redefining A as A(PT)−1
and C as C(PT)−1, it suffices to prove the lemma when B = diag{λ1, . . . , λq} and D = diag{μ1, . . . , μq}.











(λi + μi )−1(ai + ci )(ai + ci )T.
We wish to show that λ−1i ai a
T
i + μ−1i ci cTi  (λi + μi )−1(ai + ci )(ai + ci )T or equivalently λ2i ci cTi +
μ2i ai a
T
i  λiμi (ai cTi + ci aTi ). The desired inequality holds if, for any x ,
(λi x
Tci )
2 + (μi xTai )2  2λiμi (xTai )(xTci ),
which is obvious from the Cauchy–Schwartz inequality. The foregoing inequality becomes an equality if
and only if λi ci = μi ai . Thus, the equality in (A1) holds if and only if AB−1 = C D−1. 
APPENDIX B
Consistency of the maximum likelihood estimator of full data under local alternatives
By the profile likelihood theory (Murphy & van der Vaart, 2000),
log plk(β) = log plk(β̂k) − 1
2
(β − β̂k)TIk(βk)(β − β̂k) + op
(
n1/2‖β − βk‖ + 1
)2
for β in a neighbourhood of the true value of βk . Denote the true value of β by β0. Because β̂k − βk =










(β − β̂k)TIk(β̂k)(β − β̂k) + op
(
n1/2‖β − β0‖ + 1
)2





(β − β̂k)TIk(β̂k)(β − β̂k).









(β − β̂k)Ik(β̂k)(β − β̂k) + αn‖β̂ − β‖2
for some positive constant α. Thus,
log pl(β̂) − log pl(β)  αn‖β̂ − β‖2 + op(n‖β − β0‖2 + n‖β̂ − β0‖2 + 1).
Because ‖β̂ − β0‖ = O(n−1/2), the foregoing inequality implies that pl(β̂) > pl(β) for any β such that
‖β − β̂‖ = n−1/2 M for a large M . Hence, there exists a local maximum within the n−1/2 M-neighbourhood
of β̂. We define that estimator as β̃ and conclude that β̃ − β0 = Op(n−1/2).
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